Cite
HARVARD Citation
Hainsworth, J. et al. (2015). Paclitaxel/carboplatin with or without belinostat as empiric first‐line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial. Cancer. 121 (10), pp. 1654-1661. [Online].